純生信友好期刊 | 2019接收量 | 影響因子 |
J Cell Biochem | 83 | 3.40 |
J Cell Physiol | 68 | 4.50 |
Front Oncol | 60 | 4.13 |
Sci Rep | 58 | 4.01 |
Front Genet | 47 | 3.52 |
Cancers (Basel) | 43 | 6.16 |
Cancer Cell Int | 39 | 3.44 |
Aging (Albany NY) | 37 | 5.52 |
Bioinformatics | 33 | 4.53 |
J Transl Med | 24 | 4.10 |
Biomed Pharmacother | 22 | 3.74 |
Int J Mol Sci | 22 | 4.18 |
EBioMedicine | 18 | 6.68 |
J Cell Mol Med | 18 | 4.66 |
Nucleic Acids Res | 12 | 11.15 |
Breast Cancer Res Treat | 11 | 3.47 |
Epigenomics | 11 | 4.40 |
Int J Cancer | 11 | 4.98 |
Brief Bioinform | 10 | 9.10 |
Oncogene | 10 | 6.63 |
純生信友好期刊 | 影響因子 | 2019接收量 |
Nat Commun | 11.88 | 6 |
Nucleic Acids Res | 11.15 | 12 |
Brief Bioinform | 9.10 | 10 |
Clin Cancer Res | 8.91 | 7 |
J Immunother Cancer | 8.68 | 7 |
Cancer Res | 8.38 | 5 |
EBioMedicine | 6.68 | 18 |
Oncogene | 6.63 | 10 |
Cancers (Basel) | 6.16 | 43 |
Mol Oncol | 5.96 | 7 |
Cell Death Dis | 5.96 | 6 |
J Clin Med | 5.69 | 7 |
J Exp Clin Cancer Res | 5.65 | 7 |
Aging (Albany NY) | 5.52 | 37 |
Clin Epigenetics | 5.50 | 7 |
Oncoimmunology | 5.33 | 6 |
Cancer Epidemiol Biomarkers Prev | 5.06 | 5 |
Int J Cancer | 4.98 | 11 |
Cancer Immunol Immunother | 4.90 | 6 |
Cancer Sci | 4.75 | 7 |
Cancer Gene Ther | 4.68 | 5 |
J Cell Mol Med | 4.66 | 18 |
Bioinformatics | 4.53 | 33 |
J Cell Physiol | 4.50 | 68 |
Mol Cancer Res | 4.48 | 5 |
PLoS Comput Biol | 4.43 | 5 |
Epigenomics | 4.40 | 11 |
Gynecol Oncol | 4.39 | 7 |
Int J Mol Sci | 4.18 | 22 |
Front Oncol | 4.13 | 60 |
J Transl Med | 4.10 | 24 |
Sci Rep | 4.01 | 58 |
Carcinogenesis | 4.00 | 7 |
Front Pharmacol | 3.85 | 6 |
Biomed Pharmacother | 3.74 | 22 |
Oral Oncol | 3.73 | 5 |
Ann Transl Med | 3.69 | 6 |
Int J Oncol | 3.57 | 9 |
Front Genet | 3.52 | 47 |
Breast Cancer Res Treat | 3.47 | 11 |
Life Sci | 3.45 | 5 |
Cancer Cell Int | 3.44 | 39 |
World J Gastroenterol | 3.41 | 7 |
Mol Carcinog | 3.41 | 5 |
J Cell Biochem | 3.40 | 83 |
文章名 | 雜志 | 影響因子 |
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits. | Cancer Res | 8.378 |
Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues.(泛癌) | ||
Identifying and targeting cancer-specific metabolism with network-based drug target prediction.(泛癌) | EBioMedicine | 6.68 |
Pathway-based biomarker identification with crosstalk analysis for robust prognosis prediction in hepatocellular carcinoma. | ||
Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.(泛癌) | ||
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. | ||
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma. | ||
Comprehensive characterization of the rRNA metabolism-related genes in human cancer.(泛癌) | Oncogene | 6.634 |
Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments. | ||
Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling | Cancers (Basel) | 6.16 |
The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target. | ||
KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy.免疫浸潤(rùn) | ||
Clinical Impact of RANK Signalling in Ovarian Cancer. | ||
Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC. | Mol Oncol | 5.962 |
Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications. | ||
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma. | Aging (Albany NY) | 5.515 |
TPM2 as a potential predictive biomarker for atherosclerosis.非腫瘤 | ||
An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer. | ||
Identification and validation of four hub genes involved in the plaque deterioration of atherosclerosis. | ||
Identification of potential blood biomarkers for Parkinson's disease（非腫瘤）by gene expression and DNA methylation data integration analysis. | Clin Epigenetics | 5.496 |
聯(lián)系客服
